iqvia glp-1 prescriptions semaglutide tirzepatide q3 2024 us Doctors and Obesity: Are healthcare professionals ready for the new anti-obesity medications? Eli Lilly Stock Will 'Dominate' – Global Medicines Outlook 2024-2028 |

It impacts an individuals quality of life, especially if epilepsy is resistant to treatment

GLP-1 drugs reduce risk of addiction as well as deaths and overdose GLP-1 drugs may help reduce the risk of addiction to alcohol, cannabis, cocaine, nicotine, and opioids, a large US study has reported

GLP-1s offer significant promise to millions of Americans living with obesity, diabetes and/or cardiovascular disease, but their unprecedented demand and high price tags are creating challenging downstream impacts including fluctuating supply, inconsistent clinical support, and runaway cost trajectory

While trans fats are out here causing chaos (bloating, cravings, inflammation), healthy fats are total overachievers